The VERTEX NEO Ultra Bench-Top Vacuum FT-IR System is a fully automated vacuum FT-IR instrument that provides high resolution ...

Using a kind of novel linker technology, the startup is developing versions of incretin and non-incretin therapies that can ...

SAN FRANCISCO - Bruker Corporation (NASDAQ:BRKR) has acquired AST Revolution, LLC, a developer of rapid antimicrobial susceptibility testing solutions, according to a press release statement from ...

Bruker Corporation today announced the launch of the VERTEX NEO Ultra, its most advanced and versatile benchtop vacuum Fourier-Transform Infrared (FT-IR) spectrometer. Building on the VERTEX NEO ...

It flipped to a GAAP net loss in its third quarter, although on a non-GAAP basis it was in the black. It beat on both the top and bottom lines. Bruker, which specializes in the supply of medical ...

During Vertex’s third-quarter presentation, Chief Commercial Officer Duncan McKechnie cited several numbers that suggest the launch of its long-awaited, non-opioid pain reliever Journavx is trending ...

The company is tapping the market for at least $600 million in fresh capital. It will use the funds chiefly to retire debt. Just after market close on Tuesday, Bruker announced that it was floating a ...

Shares of Bruker slipped after the maker of scientific products started a public offering of $600 million of Series A mandatory convertible preferred stock. The stock was 13% lower, at $28.86, midday ...

Bruker Corporation (NASDAQ:BRKR) reported worse-than-expected second-quarter financial results and cut its FY25 guidance on Monday. Bruker reported quarterly earnings of 32 cents per share which ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...